PhenoVista Biosciences

About:

PhenoVista Biosciences provides high content imaging-based phenotypic assay development and screening services.

Website: http://phenovista.com/

Twitter/X: phenovista

Top Investors: BroadOak Capital Partners, U.S. Department of Health & Human Services, Life Sciences Corporate Venture Capital

Description:

PhenoVista Biosciences is a niche contract research organization (CRO) providing high content imaging-based phenotypic assay development and screening services. Using state-of-the-art technology, PhenoVista Biosciences performs phenotypic screen feasibility, development, and full-scale campaigns. PhenoVista Biosciences' team of cell biologists work closely with clients to get the data they need on time and on budget.

Total Funding Amount:

$3.15M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2014-01-01

Contact Email:

contact(AT)phenovista.com

Founders:

James Evans

Number of Employees:

11-50

Last Funding Date:

2022-12-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai